General Information
Version
9.4
Revision date
2025-05-17
Product name
Sumatriptan Succinate
CAS No.
103628-48-4
REACH No
A
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d, H412
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Reproductive toxicity, (Category H361d: Suspected of damaging the unborn 2) child. Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.
Signal word
Warning Warning
Hazard statements
H361d Suspected of damaging the unborn child. H412 Harmful to aquatic life with long lasting effects. H412 Harmful to aquatic life with long lasting effects. H361d Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
